InvestorsHub Logo
icon url

cameron12x

10/14/14 2:55 PM

#23761 RE: salgovernale69 #23760

Sal--I agree with you completely. This thing is likely to skyrocket, and soon. I'm personally betting on it.

However, most of us with large investments here tirelessly attempt to uncover all unturned stones, almost to the point of paranoia. As good as everything appears, there is almost NEVER a "slam dunk" in biotech.

I've learned the hard way before. :)
icon url

furbush87

10/14/14 2:59 PM

#23762 RE: salgovernale69 #23760

Yeah, he made the statement that there were no risks, paused then added in that bad data would be a risk, changed that to someone dying, then went on to say there were no risk in the short term. So with a CEO making that statement, to me means no risks. Especially when we have 28/30 patients. If the last 2 patients were complete responders that would be significant, if they are non responders it will barely move the needle down. MCC is not priced in to the current stock, nor is the 1 year survival data. Honestly I don't even think interim P2 data is priced in.
icon url

Psychodad1620

10/14/14 4:05 PM

#23766 RE: salgovernale69 #23760

"Funny how some of you guys read into statements like that but you don't have the ability to read into the fact that high profile doctors and scientists are joining the company at an alarming rate or the fact that we just hired an in-house legal department. "

But we want results now!!!
WaaaaaaaaaaWaaaaaaaaaa
icon url

mmillionaire

10/14/14 4:10 PM

#23770 RE: salgovernale69 #23760

Excuse me, but that is exactly what we are looking for, rocket science. Science that will rocket this stock.